Literature DB >> 23075089

Restrictive lung disease is an independent predictor of exercise intolerance in the adult with congenital heart disease.

Salil Ginde1, Peter J Bartz, Garick D Hill, Michael J Danduran, Julie Biller, Jane Sowinski, James S Tweddell, Michael G Earing.   

Abstract

BACKGROUND/
OBJECTIVES: Following repair of congenital heart disease (CHD), adult patients are at risk for reduced exercise capacity. Restrictive lung disease (RLD) may contribute to reduced exercise capacity in this population. The aim of this study was to determine the prevalence of RLD and its impact on exercise tolerance in the adult with CHD.
METHODS: One hundred consecutive adult patients with CHD, who underwent routine cardiopulmonary exercise testing with spirometry, were evaluated. Clinical data were obtained by retrospective chart review.
RESULTS: Patients from 10 major diagnostic groups were identified. The median age for the cohort was 31 years (range 18-63) and included 43 males and 57 females. Most patients, 79%, had at least one previous surgical procedure. Based on spirometry and flow/volume loops, 50 patients were classified as normal pulmonary function, 44 patients had patterns suggestive of RLD, 4 suggestive of mixed (obstructive and restrictive), and 2 indeterminate. Risk factors associated with RLD include history of multiple thoracotomies (odds ratio = 9.01, P =.05) and history of atrial arrhythmias (odd ratio = 4.25, P =.05). Overall, 56% of the patients had abnormal exercise capacity. Spirometry suggestive of RLD was a significant risk factor for decreased exercise capacity (odds ratio = 3.65, P =.03). Patients with spirometry suggesting RLD also had lower exercise duration (P =.004) and a higher New York Heart Association Functional Class (P =.02). History of previous surgery and decreased heart rate reserve were also significant risk factors for decreased exercise capacity.
CONCLUSION: Abnormal spirometry suggestive of RLD is common in the adult with CHD and is a significant risk factor for decreased exercise tolerance in this population. Further studies are needed to evaluate the relationship between RLD and exercise intolerance and its relationship to mortality in the adult with CHD.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23075089      PMCID: PMC4832600          DOI: 10.1111/chd.12010

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  24 in total

1.  How accurate is spirometry at predicting restrictive pulmonary impairment?

Authors:  S D Aaron; R E Dales; P Cardinal
Journal:  Chest       Date:  1999-03       Impact factor: 9.410

2.  Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term.

Authors:  Ryo Inuzuka; Gerhard-Paul Diller; Francesco Borgia; Leah Benson; Edgar L W Tay; Rafael Alonso-Gonzalez; Margarida Silva; Menelaos Charalambides; Lorna Swan; Konstantinos Dimopoulos; Michael A Gatzoulis
Journal:  Circulation       Date:  2011-12-06       Impact factor: 29.690

3.  Five- to fifteen-year follow-up after Fontan operation.

Authors:  D J Driscoll; K P Offord; R H Feldt; H V Schaff; F J Puga; G K Danielson
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

Review 4.  Exercise studies in tetralogy of Fallot: a review.

Authors:  H U Wessel; M H Paul
Journal:  Pediatr Cardiol       Date:  1999 Jan-Feb       Impact factor: 1.655

5.  Role of right ventricular and pulmonary functional abnormalities in limiting exercise capacity in adults with congenital heart disease.

Authors:  V H Rigolin; J S Li; M W Hanson; M J Sullivan; P A Robiolio; S E Hearne; W A Baker; J K Harrison; T M Bashore
Journal:  Am J Cardiol       Date:  1997-08-01       Impact factor: 2.778

6.  Exercise capacity in adult patients with congenitally corrected transposition of the great arteries.

Authors:  P M Fredriksen; A Chen; G Veldtman; S Hechter; J Therrien; G Webb
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

Review 7.  Pulmonary-function testing.

Authors:  R O Crapo
Journal:  N Engl J Med       Date:  1994-07-07       Impact factor: 91.245

8.  Dyspnoea and exercise intolerance during cardiopulmonary exercise testing in patients with univentricular heart. The effects of chronic hypoxaemia and Fontan procedure.

Authors:  L Iserin; T P Chua; J Chambers; A J Coats; J Somerville
Journal:  Eur Heart J       Date:  1997-08       Impact factor: 29.983

Review 9.  Pulmonary function and ventilatory limitation to exercise in congenital heart disease.

Authors:  Paolo T Pianosi; Jonathan N Johnson; Attilio Turchetta; Bruce D Johnson
Journal:  Congenit Heart Dis       Date:  2009 Jan-Feb       Impact factor: 2.007

10.  Lung function in relation to haemodynamic status after atrial redirection for transposition of the great arteries.

Authors:  T Gilljam; R Sixt
Journal:  Eur Heart J       Date:  1995-12       Impact factor: 29.983

View more
  14 in total

1.  Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity.

Authors:  Alexander R Opotowsky; Michael J Landzberg; Michael G Earing; Fred M Wu; John K Triedman; Alicia Casey; Dawn A Ericson; David Systrom; Stephen M Paridon; Jonathan Rhodes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-05-02       Impact factor: 4.733

Review 2.  Transplant and mechanical circulatory support in patients with adult congenital heart disease.

Authors:  James Monaco; Amber Khanna; Prateeti Khazanie
Journal:  Heart Fail Rev       Date:  2020-07       Impact factor: 4.214

3.  Exercise Capacity in Patients with Pulmonary Atresia with Intact Ventricular Septum: Does the Type of Surgical Repair Matter?

Authors:  Anusha Konduri; Chenni Sriram; Deemah Mahadin; Sanjeev Aggarwal
Journal:  Pediatr Cardiol       Date:  2022-06-09       Impact factor: 1.655

Review 4.  Preoperative Evaluation of Adult Congenital Heart Disease Patients for Non-cardiac Surgery.

Authors:  Jennifer F Gerardin; Michael G Earing
Journal:  Curr Cardiol Rep       Date:  2018-07-21       Impact factor: 2.931

5.  The Identification and Impact of Abnormal Spirometry Patterns on Exercise Capacity in Pediatric Patients with Fontan Palliation.

Authors:  Daiji Takajo; Chenni S Sriram; Preetha L Balakrishnan; Sanjeev Aggarwal
Journal:  Pediatr Cardiol       Date:  2021-06-14       Impact factor: 1.655

6.  Prevalence and associated factors of preoperative functional disability in elective surgical patients over 55 years old: a prospective cohort study.

Authors:  Mitsuru Ida; Yusuke Naito; Yasunori Matsunari; Yuu Tanaka; Satoki Inoue; Masahiko Kawaguchi
Journal:  J Anesth       Date:  2018-03-27       Impact factor: 2.078

7.  Feeding dysfunction in children with single ventricle following staged palliation.

Authors:  Garick D Hill; Alan H Silverman; Richard J Noel; Pippa M Simpson; Julie Slicker; Ann E Scott; Peter J Bartz
Journal:  J Pediatr       Date:  2013-10-22       Impact factor: 4.406

8.  Does Restrictive Lung Function Affect the Exercise Capacity in Patients with Repaired Tetralogy of Fallot?

Authors:  Jyothsna Akam-Venkata; Chenni Sriram; Michelle French; Roxann Smith; Sanjeev Aggarwal
Journal:  Pediatr Cardiol       Date:  2019-09-17       Impact factor: 1.655

9.  Non-cardiac comorbidities in adults with inherited and congenital heart disease: report from a single center experience of more than 800 consecutive patients.

Authors:  Rhoia Clara Neidenbach; Eckart Lummert; Matthias Vigl; Reinhard Zachoval; Michael Fischereder; Andrea Engelhardt; Claudia Pujol; Renate Oberhoffer; Nicole Nagdyman; Peter Ewert; Michael Hauser; Harald Kaemmerer
Journal:  Cardiovasc Diagn Ther       Date:  2018-08

10.  Reduced Forced Vital Capacity and the Number of Chest Wall Surgeries are Associated with Decreased Exercise Capacity in Children with Congenital Heart Disease.

Authors:  Imran R Masood; Jon Detterich; Daniel Cerrone; Katherine Lewinter; Payal Shah; Roberta Kato; Arash Sabati
Journal:  Pediatr Cardiol       Date:  2021-08-07       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.